Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)
Clinical trial NCT01391546 · COMPLETED
Trial details
- NCT number
- NCT01391546
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-20
- Primary completion
- 2012-10-15
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.